N-*A. The other types of mutant each contained one or two amino acid changes also within the 2C coding region.
Racaniello and Baltimore (19) reported that a complete cloned cDNA copy of the Mahoney strain of poliovirus was infectious in mammalian cells. Semler et al. (24) showed that a similar clone containing simian virus 40 transcription and replication signals had higher specific infectivity. These observations had profound implications for the study of picornavirus genetics because they created the possibility of creating specifically designed mutant or recombinant viruses by transfecting cells with cDNA which has been modified by DNA manipulation techniques. By this technique, interstrain recombinants have been obtained for the purposes of determining the molecular basis of attenuation, as well as for further studies of antigenicity (11, 26) . This technique has also been used to generate specific mutants of poliovirus with novel phenotypes (2, 22, 25) . In this communication we describe the cloning of cDNA segments containing either the mutation for resistance to 2.0 mM guanidine or the mutations responsible for guanidine dependence into the wild-type background of an infectious clone. The viruses isolated from transfected cells were found to express the resistance or dependence phenotype, demonstrating that mutations in protein 2C are directly responsible for altered guanidine sensitivity.
The lack of unique restriction sites at the boundaries of the 2C region of our infectious clones (nucleotides 4124 to 5110) caused us to adopt the strategy for cloning this region from the resistant and dependent mutants depicted in Fig. 1 . We synthesized double-stranded DNA from viral RNA of the guanidine-resistant (GR2) or -dependent (GD1) mutant by using reverse transcriptase as described previously (16) . The cloning vector pSP-1 was prepared by addition of a BglII linker (CAGATCTG) (New England BioLabs, Inc.) at the unique EcoRI site of pXf3 (13) . After digestion of pSP-1 with PstI and BglII, the large fragment containing the gene for tetracycline resistance was purified and ligated to the double-stranded DNA which had been digested with these two enzymes. Tetracycline-resistant colonies of Escherichia coli HB101 were obtained after transformation with the ligation mixture and screened for the presence of poliovirus-specific inserts by rapid plasmid preparations and restriction endonuclease digestions (24 Sequence analysis of genomic RNA of GR2 and GD1 from nucleotides 4048 to 5138 revealed an asparagine-to-glycine change within 2C (amino acid 179, nucleotides 4658 to 4660) in both mutants and an isoleucine-to-methionine change within 2C in GD1 (amino acid 227, nucleotides 4802 to 4804) (17) . We have previously shown that the resistance of another mutant containing the N-*G change maps to the 3' side of nucleotide 4444 (17) . Thus, pSP-3R and pSP-3D contain regions of the mutant genomes that should not be needed for expression of the altered guanidine phenotypes.
The following strategy was used to eliminate these additional regions.
A full-length poliovirus insert was isolated from pDS303 (24) and cloned into the EcoRI site of pSVO, which contained the simian virus 40 origin and enhancer sequences. The resulting clone (pSVO-polio) was found to have as high a specific infectivity as pEV104 (24; Putnak and Wimmer, unpublished data). A PstI-BglII fragment from pSVO-polio was ligated to the PstI-BglII fragment from pSP-1 described above resulting in a plasmid (pSP-2W) containing wild-type poliovirus sequences from nucleotides 3417 to 5601. pSP-2W was digested with BstEII and NsiI, and the large fragment Full-length clones containing the resistance or dependence regions were generated by the strategy depicted in Fig. 2 . A 7,900-base-pair PstI-BglII fragment was isolated from pSVO-polio by partial digestion with PstI and complete digestion with BglII. This fragment was ligated to the PstIBglII poliovirus specific insert from pSP-4D, and after transformation a full-length clone (pSV-PGD) was identified. Our attempts to obtain a full-length resistant clone by this strategy were unsuccessful for reasons that are not clear. We overcame this problem by performing a three-fragment ligation. pSVO-polio was digested with NheI and BglII, and the resulting fragments (7.0 and 3.1 kilobases) were purified. The 3.1-kb fragment was digested with PstI, and a 0.9-kb fragment was purified. Ligation of the 7.0-kb and 0.9-kb fragments and the poliovirus-specific insert from pSP-4R resulted in a full-length clone (PSV-PGR). The N-*G mutation results in loss of a HinFI site. We verified that PSV-PGD and poliovirus containing the 2C region from a guanidine-resistant or PSV-PGR contained mutant sequences by comparing the HinFI pattern of these clones to that obtained with pSVOpolio.
To test whether our full-length clones containing the resistance or dependence region would produce infectious virus on introduction of plasmid DNA into primate cells, we carried out transfection of COS-1 cells by using the modified calcium phosphate coprecipitation technique (24) . COS-1 cells were grown to confluency in 6-cm (diameter) plastic dishes and transfected in duplicate with 50 ng of pSVOpolio, PSV-PGD, or PSV-PGR with a 20% glycerol shock. The plates were incubated at 37°C for 2 days after which half received 2.0 mM guanidine hydrochloride. Addition of guanidine before this time caused total cell death in mocktransfected plates. After 7 days at 37°C, those plates in which the cells were no longer attached were subjected to three cycles of freeze-thawing, the cell debris was removed by centrifugation, and the virus-containing supernatants were titrated in the absence or presence of 2.0 mM guanidine hydrochloride as previously described (17) .
The results of two separate experiments are presented in Table 1 absence of drug, indicating that this virus was as resistant to guanidine as was GR2. Virus produced by transfection of this plasmid in the presence of guanidine was equally resistant (data not shown). Transfection of cells in the absence of guanidine with pSV-PGD failed to produce any cytopathic effect (data not shown). Cells transfected with PSV-PGD in the presence of guanidine produced virus that displayed a 280-to 570-fold higher titer in the presence of drug than in its absence, indicating that this virus was as dependent on guanidine as was GD1.
In conclusion, the results presented here demonstrated that the N->G mutation in GR2 was directly responsible for its resistance to 2.0 mM guanidine hydrochloride and addition of the I-+M mutation in GD1 resulted in a virus that required guanidine for growth. The results demonstrated that transfection of cells with cDNA clones is a powerful tool for identifying the genome location of mutations in poliovirus and for demonstrating that a mutation is responsible for an observed phenotype.
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